Mirum Pharmaceuticals, Inc. financial data

Symbol
MIRM on Nasdaq
Industry
Pharmaceutical Preparations
Location
989 East Hillsdale Boulevard, Suite 300, Foster City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 364 % -21%
Quick Ratio 20.4 % +17.2%
Debt-to-equity 178 % -2.21%
Return On Equity -42.3 % +59.4%
Return On Assets -15.2 % +58.8%
Operating Margin -31.3 % +59.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48M shares +2.98%
Common Stock, Shares, Outstanding 48M shares +2.95%
Entity Public Float 830M USD +36.3%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 47.8M shares +16.3%
Weighted Average Number of Shares Outstanding, Diluted 47.8M shares +16.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 307M USD +112%
Operating Income (Loss) -96M USD +13.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -98M USD +40%
Income Tax Expense (Benefit) 1.83M USD +39.4%
Net Income (Loss) Attributable to Parent -99.8M USD +39.2%
Earnings Per Share, Basic -2.05 USD/shares +52.2%
Earnings Per Share, Diluted -2.05 USD/shares +52.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 223M USD -26.4%
Accounts Receivable, after Allowance for Credit Loss, Current 68.5M USD +43.3%
Inventory, Net 21.6M USD -2.95%
Assets, Current 387M USD -0.5%
Property, Plant and Equipment, Net 1.21M USD +54%
Operating Lease, Right-of-Use Asset 9.14M USD +540%
Intangible Assets, Net (Excluding Goodwill) 256M USD -0.99%
Other Assets, Noncurrent 5.38M USD +256%
Assets 668M USD +2.65%
Accounts Payable, Current 9.55M USD +29.5%
Employee-related Liabilities, Current 23.1M USD +69.6%
Accrued Liabilities, Current 105M USD +58.1%
Liabilities, Current 116M USD +55%
Operating Lease, Liability, Noncurrent 8.48M USD +877%
Other Liabilities, Noncurrent 3.97M USD +56643%
Liabilities 436M USD +14.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 920K USD
Retained Earnings (Accumulated Deficit) -620M USD -19.2%
Stockholders' Equity Attributable to Parent 232M USD -13.8%
Liabilities and Equity 668M USD +2.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.2M USD
Net Cash Provided by (Used in) Financing Activities 1.21M USD -90.7%
Net Cash Provided by (Used in) Investing Activities 27M USD -26%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 48M shares +2.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.5M USD -22.9%
Deferred Tax Assets, Valuation Allowance 143M USD +39%
Deferred Tax Assets, Gross 143M USD +38.7%
Operating Lease, Liability 9.99M USD +412%
Payments to Acquire Property, Plant, and Equipment 13K USD -68.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.4M USD +41%
Lessee, Operating Lease, Liability, to be Paid 12M USD +463%
Operating Lease, Liability, Current 1.51M USD +39.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.44M USD +588%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.38M USD +101%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.97M USD +1045%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.51M USD +2119%
Deferred Tax Assets, Operating Loss Carryforwards 40.5M USD +17.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 10.5M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.51M USD +2123%
Operating Lease, Payments 289K USD +10.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 22.4M USD +256%
Depreciation, Depletion and Amortization 5.66M USD +324%
Share-based Payment Arrangement, Expense 44.9M USD +39.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%